Canada’s decision to legalize the recreational use of cannabis has allowed the rise of an emerging investment market. The cannabis public sector has become one of the most followed industries for investors.
As such, the Investing News Network brings investors a collection of stories on the critical transition and its impact on the public markets.
Investors have eagerly anticipated the start of adult-use cannabis sales in Canada as they wait to see which companies will see positive numbers from this new market.
While cannabis investors will have to wait for concrete data to arrive for the first few days and weeks of legal sales, the event brought attention from the public to the space.
The Investing News Network (INN) provided coverage of legalization in the week leading up to the event and immediately after — see below for a round-up of our content on this critical event in Canada.
How to Invest in Cannabis: Start Here: INN put together a guide for new investors joining the cannabis public market. Everything you would want to know about this emerging play.
Financial Experts Say This is How Pot Legalization Will Affect Investors: Prior to legalization, a collection of financial experts, including portfolio managers and executives, shared their views with INN on what might happen after legalization.
Cannabis Stocks Drop on Legalization Date: Despite the excitement in Canada and internationally over the legalization of adult-use cannabis, the stock market took a hit that has continued with mounting losses for pot stocks.
No Market Buzz on Cannabis Legalization, Says Portfolio Manager: Greg Taylor, portfolio manager with Purpose Investments, gave his opinion on sentiment for cannabis stocks after the much-anticipated October 17 legalization date.
Setback Potential for Investors After Legalization, ETF Exec Says: Mark Noble, senior vice president of ETF strategy with Horizons ETFs, also told INN his expectations for the cannabis public market after legalization. Watch the interview below:
Cannabis Shortage Won’t be Fixed with New Licenses, Says CEO: Greg Engel, CEO of Organigram Holdings (TSXV:OGI), told INN what he thinks is needed to effectively combat the shortage of legal recreational cannabis seen in Canada.
Lift & Co. Looks to Train All Cannabis Retail Staff: A Canadian cannabis company wants to make its training program for retail staff workers in cannabis shops the “no-brainer choice” for retailers looking to comply with guidance from the Canadian government.
The Future of Cannabis in the Retail Industry: While the Canadian cannabis public market has been a story full of excitement on the producers’ side, retail plays could provide a strategic alternative and offer a new entry point into the cannabis market.
What are the Risks for Cannabis Investors Crossing to the US?: As legalization hits Canada, the US still holds cannabis and related activities under federal scrutiny. INN asked legal experts what the level of risk will look like for investors in the space.
Canadian Cannabis Companies on US Exchanges Expand Reach: With the cannabis market hitting a new benchmark of maturation with legal adult-use sales, leading companies are listing on US exchanges, increasing options for US investors eager to get in the market.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).